Overture Life

Overture Life is a clinical-stage biotechnology company specializing in the automation of in vitro fertilization (IVF) processes. Founded in 2017 by Martin Varsavsky, Santiago Munné, and José Horcajadas, the company integrates engineering, reproductive medicine, and regulatory-grade validation to modernize embryology lab procedures. Their goal is to make IVF more reproducible, efficient, and cost-effective, ultimately improving pregnancy outcomes and expanding access to fertility care.